| Value | ₹27.75 Cr |
|---|
NSE filing, NSE: ACCPL. Summary written from the filing by ALFA Finder's alert engine.
Accretion Pharmaceuticals Ltd: key numbers
- Share price
- ₹190.05
- Market cap
- ₹211.3 Cr
- Revenue (annual)
- ₹89.63 Cr
- Net profit (annual)
- ₹9.67 Cr
- P/E (TTM)
- 21.9×Sector 45.9×
- Promoter holding
- 73.52%+0.00% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Pharmaceuticals Ltd
All →Accretion Pharmaceuticals Annual General Meeting
Accretion Pharmaceuticals Limited announced the results of its postal ballot, where shareholders approved five special resolutions, including increasing borrowing limits and charging company assets.
Accretion Pharmaceuticals Other Announcement
Accretion Pharmaceuticals Limited submitted the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Accretion Pharmaceuticals Annual General Meeting
Accretion Pharmaceuticals Limited issued a postal ballot notice to shareholders to seek approval for altering the company's Memorandum of Association (Object Clause).
Accretion Pharmaceuticals Other Announcement
Accretion Pharmaceuticals Limited approved an alteration to its Memorandum of Association to expand its business objects. The Board also approved increased borrowing and investment limits subject to shareholder approval.
Accretion Pharmaceuticals Annual General Meeting
Accretion Pharmaceuticals Limited held its 3rd Annual General Meeting on August 27, 2026. The meeting transacted business including the adoption of financial statements and director re-appointment.
Accretion Pharmaceuticals Other Announcement
Accretion Pharmaceuticals Limited has provided the web link for shareholders to access its Annual Report for FY 2025-26 and the 3rd AGM notice.
Other results correction announcements
All →Amalgamated Electricity Company Results Correction
Amalgamated Electricity revised its board outcome to correct a director's designation in the September 2026 balance sheet. The resubmission re-encloses the unaudited results and limited review report.
Manipal Payment and Identity Solutions Results Correction
Manipal Payment and Identity Solutions clarified two NSE observations on its 01 October 2026 financial results. It stated it has one operating segment and that the results PDF was machine-readable.
Tamilnad Mercantile Bank Results Correction
TMB clarified its ₹304.24 crore ECL provision is proactive, not a regulatory shortfall. The ECL framework applies from April 2027 under RBI rules.
Punjab National Bank Results Correction
Punjab National Bank re-submitted its unchanged September 2026 quarter and half-year results in machine-readable format. No figures, disclosures or other information were modified from the earlier filing.
Gateway Distriparks Results Correction
Gateway Distriparks issued a revised Q2 FY27 results press release to correct a typographical error in the earlier filing. The financial figures remain materially unchanged.
Padmanabh Alloys & Polymers Results Correction
Padmanabh Alloys revised its unaudited September 2026 quarter and half-year results to correct a deferred tax typing error. Profit, EPS and balance sheet figures are updated.